Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors
Open Access
- 19 March 2022
- journal article
- review article
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 25, 78-97
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA153165)
- National Institutes of Health (CA196947)
- College of Veterinary Medicine, Purdue University
- Purdue Research Foundation
- National Research Foundation of Korea (2021R1A2C301016611)
- National Research Foundation of Korea (2016M3A9B5942352)
This publication has 152 references indexed in Scilit:
- Same or Not the Same? Comparison of Adipose Tissue-Derived Versus Bone Marrow-Derived Mesenchymal Stem and Stromal CellsStem Cells and Development, 2012
- Adipose-derived Stem Cells as Therapeutic Delivery Vehicles of an Oncolytic Virus for GlioblastomaMolecular Therapy, 2010
- Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy ModelClinical Cancer Research, 2009
- Radiation Increases Invasion of Gene-Modified Mesenchymal Stem Cells into TumorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel‐induced cytotoxicityThe Prostate, 2009
- Pulmonary Passage is a Major Obstacle for Intravenous Stem Cell Delivery: The Pulmonary First-Pass EffectStem Cells and Development, 2009
- The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cellsExperimental Cell Research, 2008
- Mesenchymal Stem Cells: Revisiting History, Concepts, and AssaysCell Stem Cell, 2008
- Adipose Tissue–Derived Human Mesenchymal Stem Cells Mediated Prodrug Cancer Gene TherapyCancer Research, 2007
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006